Botulinum Toxin-A Injections Into Neurogenic Overactive Bladder-To Include or Exclude the Trigone? A Prospective, Randomized, Controlled Trial

被引:58
作者
Abdel-Meguid, Taha A. [1 ,2 ]
机构
[1] King Abdulaziz Univ Med City, Dept Urol, Jeddah, Saudi Arabia
[2] Menia Univ, Dept Urol, El Minia, Egypt
关键词
urinary bladder; neurogenic; spinal cord injuries; botulinum toxin type A; urinary incontinence; urodynamics; IDIOPATHIC DETRUSOR OVERACTIVITY; INTRADETRUSOR INJECTIONS; INCONTINENCE; STANDARDIZATION; TERMINOLOGY;
D O I
10.1016/j.juro.2010.08.028
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The short-term outcomes of initial detrusor injections vs combined detrusor-trigone botulinum toxin-A injections were determined in patients with spinal cord injury-neurogenic detrusor overactivity. Materials and Methods: Adults with refractory spinal cord injury-neurogenic detrusor overactivity who strictly discontinued anticholinergics were recruited for the study. At a 1: 1 ratio patients randomly received 300 U botulinum toxin-A intradetrusor injections excluding the trigone (detrusor arm) or 200 U intradetrusor plus 100 U intratrigonal injections (combined arm). Study end points were determination of the impact on incontinence episodes, complete dryness, quality of life, reusing anticholinergics, maximum detrusor pressure, reflex volume, maximum cystometric capacity, vesicoureteral reflux and adverse events. Patients were evaluated at baseline, and 2, 8, 12 and 18 weeks after injection. Statistical significance was considered at p<0.05. Results: Analysis included 18 patients per arm with no significant baseline differences. On within group analysis all parameters improved significantly compared to baseline. On between group analysis in the detrusor vs the combined arm at week 8 incontinence decreased by 52.4% vs 80.9% (number needed to treat 1.91 vs 1.23 patients, p<0.001), complete dryness was achieved in 33.3% vs 66.7% of patients (number needed to treat 3 vs 1.5, p<0.001) and quality of life score was decreased by 46.76% vs 48.13% (number needed to treat 2.14 vs 2.08, p<0.44). The absolute difference was 60% vs 82.5% for reflex volume (p<0.001), 66.2% vs 68.4% for maximum cystometric capacity (p<0.22) and -42.3% vs -41.9% for maximum detrusor pressure (p<0.21). At week 18 anticholinergics were needed again in 9 (50%) and 4 patients (22.2%) patients, respectively. No patient showed new or upgraded vesicoureteral reflux or reported significant adverse events. Conclusions: In the short term all parameters improved significantly in each arm. The superiority of including rather than excluding the trigone was significant.
引用
收藏
页码:2423 / 2428
页数:6
相关论文
共 45 条
  • [31] Application of methylene blue as an improvement of the injection technique of botulinum toxin A in the treatment of refractory idiopathic overactive bladder: prospective, single-blind (patient-blind), randomized trial
    Szczypior, Michat
    Polom, Wojciech
    Waz, Piotr
    Matuszewski, Marcin
    VIDEOSURGERY AND OTHER MINIINVASIVE TECHNIQUES, 2019, 14 (03) : 420 - 426
  • [32] Botulinum toxin injections for Japanese patients with urinary incontinence caused by neurogenic detrusor overactivity: Clinical evaluation of onabotulinumtoxinA in a randomized, placebo-controlled, double-blind trial with an open-label extension
    Honda, Masashi
    Yokoyama, Osamu
    Takahashi, Ryosuke
    Matsuda, Tatsuma
    Nakayama, Takashi
    Mogi, Takao
    INTERNATIONAL JOURNAL OF UROLOGY, 2021, 28 (09) : 906 - 912
  • [33] Effect of Botulinum Toxin A on Scar Healing after Thyroidectomy: A Prospective Double-blind Randomized Controlled Trial
    Bae, Dong Sik
    Koo, Do Hoon
    Kim, Ji Eun
    Cho, Jae-mahn
    Park, Jun-Ook
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (03)
  • [34] Short-term effect of magnetic stimulation added to bladder training in women with idiopathic overactive bladder: A prospective randomized controlled trial
    Tezer, Tevfik
    Yildiz, Necmettin
    Sarsan, Ayse
    Alkan, Hakan
    NEUROUROLOGY AND URODYNAMICS, 2022, 41 (06) : 1380 - 1389
  • [35] Evaluating repetitive transcranial magnetic stimulation for neurogenic overactive bladder management in stroke survivors: A randomized sham-controlled trial protocol
    Ali, Mohammed Usman
    Kwan, Crystal
    Fong, Kenneth Nai-Kuen
    Kranz, Georg S.
    Winser, Stanley John
    Kannan, Priya
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2024, 300 : 182 - 189
  • [36] A Double-Blind Randomized Controlled Trial Investigating the Most Efficacious Dose of Botulinum Toxin-A for Sialorrhea Treatment in Asian Adults with Neurological Diseases
    Mazlan, Mazlina
    Rajasegaran, Shivani
    Engkasan, Julia Patrick
    Nawawi, Ouzreiah
    Goh, Khean-Jin
    Freddy, Saini Jeffery
    TOXINS, 2015, 7 (09) : 3758 - 3770
  • [37] Which combination is most effective in women with idiopathic overactive bladder, including bladder training, biofeedback, and electrical stimulation? A prospective randomized controlled trial
    Firinci, Sule
    Yildiz, Necmettin
    Alkan, Hakan
    Aybek, Zafer
    NEUROUROLOGY AND URODYNAMICS, 2020, 39 (08) : 2498 - 2508
  • [38] OnabotulinumtoxinA (botulinum toxin type A) for the treatment of Japanese patients with overactive bladder and urinary incontinence: Results of single-dose treatment from a phase III, randomized, double-blind, placebo-controlled trial (interim analysis)
    Yokoyama, Osamu
    Honda, Masashi
    Yamanishi, Tomonori
    Sekiguchi, Yuki
    Fujii, Kenji
    Nakayama, Takashi
    Mogi, Takao
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (03) : 227 - 234
  • [39] Remotely programmed sacral neuromodulation for the treatment of patients with refractory overactive bladder: a prospective randomized controlled trial evaluating the safety and efficacy of a novel sacral neuromodulation device
    Zhang, Yaoguang
    Zhang, Peng
    Tian, Xiaojun
    Chen, Guoqing
    Li, Yan
    Zhang, Yong
    Xu, Zhihui
    Wei, Zhongqing
    Zhang, Wei
    Ma, Lulin
    Shi, Benkang
    Liao, Limin
    Wang, Jianye
    WORLD JOURNAL OF UROLOGY, 2019, 37 (11) : 2481 - 2492
  • [40] Remotely programmed sacral neuromodulation for the treatment of patients with refractory overactive bladder: a prospective randomized controlled trial evaluating the safety and efficacy of a novel sacral neuromodulation device
    Yaoguang Zhang
    Peng Zhang
    Xiaojun Tian
    Guoqing Chen
    Yan Li
    Yong Zhang
    Zhihui Xu
    Zhongqing Wei
    Wei Zhang
    Lulin Ma
    Benkang Shi
    Limin Liao
    Jianye Wang
    World Journal of Urology, 2019, 37 : 2481 - 2492